Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function (Q33757657)

29 July 2017

5 references

31 July 2019

17 November 2019

15 December 2019

29 October 2020

26 January 2021

Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function (English)

1 reference

24971371

29 July 2017

main subject

cell surface receptor

1 reference

31 July 2019

4 references

31 July 2019

17 November 2019

15 December 2019

29 October 2020

1 reference

17 November 2019

1 reference

15 December 2019

1 reference

29 October 2020

leukotriene antagonists

1 reference

26 January 2021

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24971371%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

A J Theron

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24971371%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

H C Steel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24971371%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

G R Tintinger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24971371%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

C M Gravett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24971371%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

C Feldman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24971371%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

25 May 2014

6 references

Journal of Immunology Research

29 July 2017

31 July 2019

17 November 2019

15 December 2019

29 October 2020

26 January 2021

6 references

31 July 2019

17 November 2019

15 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24971371%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

29 October 2020

26 January 2021

2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24971371%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

608930

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24971371%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

10 June 2020

copyright license

5 references

31 July 2019

17 November 2019

15 December 2019

29 October 2020

Creative Commons Attribution

26 January 2021

1 reference

4 September 2020

0 references

Role of Leukotrienes and Leukotriene Modifiers in Asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Differential regulation of cysteinyl leukotriene receptor signaling by protein kinase C in human mast cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Montelukast prevents microparticle-induced inflammatory and functional alterations in human bronchial smooth muscle cells.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Pivotal role of the 5-lipoxygenase pathway in lung injury after experimental sepsis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Cys-leukotrienes promote fibrosis in a mouse model of eosinophil-mediated respiratory inflammation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Impact of montelukast on asthma associated with rhinitis, and other triggers and co-morbidities

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Antileukotriene agents for the treatment of lung disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Cysteinyl leukotriene-receptor-1 antagonists interfere with PGE2 synthesis by inhibiting mPGES-1 activity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

A randomized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Asthma therapy in pediatric patients: a systematic review of treatment with montelukast versus inhaled corticosteroids

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Managing co-morbid asthma with allergic rhinitis: targeting the one-airway with leukotriene receptor antagonists

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Montelukast in asthma: a review of its efficacy and place in therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

The Leukotrienes: Immune-Modulating Lipid Mediators of Disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Role of leukotriene receptor antagonists in the management of pediatric asthma: an update

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

The function of neutrophils in sepsis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Montelukast as a treatment modality for eosinophilic gastroenteritis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Montelukast for the treatment of asthma in the adult population

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Leukotriene D4 enhances tumor necrosis factor-α-induced vascular endothelial growth factor production in human monocytes/macrophages

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Eosinophilic oesophagitis: epidemiology, pathogenesis and management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Leukotrienes and airway inflammation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Anti-inflammatory medications for obstructive sleep apnea in children

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Leukotriene modifiers for asthma treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Archimedes. Question 2. Is oral montelukast beneficial in treating acute asthma exacerbations in children?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Cysteinyl leukotriene receptor antagonists inhibit tumor metastasis by inhibiting capillary permeability

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

A comparison of intranasal corticosteroid, leukotriene receptor antagonist, and topical antihistamine in reducing symptoms of perennial allergic rhinitis as assessed through the Rhinitis Severity Score

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Pharmacological control of neutrophil-mediated inflammation: strategies targeting calcium handling by activated polymorphonuclear leukocytes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Leukotriene modifiers in the treatment of asthma in children

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Targeting leukotrienes for the treatment of COPD?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Exercise-induced bronchoconstriction in asthmatic children: a comparative systematic review of the available treatment options

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-kappaB pathways

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Montelukast sodium for exercise-induced asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Treating patients with respiratory disease who smoke

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Cysteinyl leukotrienes induce macrophage inflammatory protein-1 in human monocytes/macrophages

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Potential role of leukotriene modifiers in the treatment of chronic obstructive pulmonary disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Review of recent results of montelukast use as a monotherapy in children with mild asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Cyclic AMP: master regulator of innate immune cell function.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Leukotriene D(4) induces gene expression in human monocytes through cysteinyl leukotriene type I receptor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Antileukotriene drugs: clinical application, effectiveness and safety

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Cysteinyl leukotrienes enhance tumour necrosis factor-alpha-induced matrix metalloproteinase-9 in human monocytes/macrophages

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Montelukast in the treatment of allergic rhinitis: an evidence-based review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Leukotriene inhibitors in the treatment of allergy and asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Critical appraisal of antileukotriene use in asthma management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Montelukast in allergic rhinitis: a systematic review and meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

CysLT1 receptor engagement induces activator protein-1- and NF-kappaB-dependent IL-8 expression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Exercise-induced bronchoconstriction in athletes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Treatment of category III A prostatitis with zafirlukast: a randomized controlled feasibility study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Single-dose agents in the prevention of exercise-induced asthma: a descriptive review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Advances in therapy with antileukotriene drugs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

A review of montelukast in the treatment of asthma and allergic rhinitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Effects of inhaled corticosteroids, leukotriene receptor antagonists, or both, plus long-acting beta2-agonists on asthma pathophysiology: a review of the evidence

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

The role of leukotrienes in asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Bronchodilator effect of zafirlukast in subjects with chronic obstructive pulmonary disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Benefit-risk assessment of antileukotrienes in the management of asthma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Pranlukast: a review of its use in the management of asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Anti-leukotriene drugs in the prevention and treatment of hepatorenal syndrome.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Leukotriene receptor antagonists in asthma therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Second-line controller therapy for persistent asthma uncontrolled on inhaled corticosteroids: the step 3 dilemma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Exercise-induced asthma: diagnosis and management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: systematic review of current evidence

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Leukotriene modifiers in pediatric asthma management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Montelukast: a review of its therapeutic potential in persistent asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Corticosteroid-sparing options in the treatment of childhood asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of "one linked airway disease".

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Treatment of aspirin-intolerant asthma with antileukotrienes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Montelukast: data from clinical trials in the management of asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Leukotriene pathway inhibitors in asthma and chronic obstructive pulmonary disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Effects of leukotriene C4 and D4, histamine and bradykinin on cytosolic calcium concentrations and adhesiveness of endothelial cells and neutrophils

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Determination of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Cysteinyl-leukotrienes induce vascular endothelial growth factor production in human monocytes and bronchial smooth muscle cells.

21 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a CysLT1 receptor-mediated mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Eosinophil superoxide anion generation induced by adhesion molecules and leukotriene D4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Eicosanoid-induced store-operated calcium entry in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Leukotrienes C4 and D4 sensitize human neutrophils for hyperreactivity to chemoattractants

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Montelukast: more than a cysteinyl leukotriene receptor antagonist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Montelukast inhibition of resting and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under flow conditions appears independent of cysLT(1)R antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Interactive inhibitory effects of formoterol and montelukast on activated human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Cyclic AMP-mediated inhibition of 5-lipoxygenase translocation and leukotriene biosynthesis in human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Pranlukast inhibits renal epithelial cyst progression via activation of AMP-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Long-term follow-up of pulmonary function in bronchial asthma patients treated with pranlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Additional effects of pranlukast in salmeterol/fluticasone combination therapy for the asthmatic distal airway in a randomized crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Leukotriene antagonists as first-line or add-on asthma-controller therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Regulating the Regulators: microRNA and Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Effects of zafirlukast on bronchial asthma and allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Effect of addition of single dose of oral montelukast to standard treatment in acute moderate to severe asthma in children between 5 and 15 years of age: a randomised, double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Short-term effects of montelukast in stable patients with moderate to severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Long-term montelukast therapy in moderate to severe COPD--a preliminary observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Leukotriene D4 potentiates fibronectin-induced migration of human lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Gastric mucosal protection against ethanol by EP2 and EP4 signaling through the inhibition of leukotriene C4 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Leukotriene D4 induces cognitive impairment through enhancement of CysLT₁ R-mediated amyloid-β generation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Leukotriene D4 induces amyloid-β generation via CysLT(1)R-mediated NF-κB pathways in primary neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Open study of pranlukast add-on therapy in intractable partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, protects mice against brain cold injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Montelukast can reduce the severity and extent of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Potential use of leukotriene inhibitors in treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Experimental otitis media with effusion induced by leukotriene D4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F608930

Clinical evaluation of response to long-term treatment with Pranlukast in patients with bronchial asthma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Zafirlukast improves pulmonary function in patients with moderate persistent asthma receiving regular inhaled steroids: a prospective randomized control study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Efficacy of zafirlukast in the treatment of patients with bronchial asthma

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058211

Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma

30 October 2018

1 reference

12 December 2020

Oral montelukast may have a role in severe and in life-threatening acute asthma

1 reference

12 December 2020

Pranlukast, a cysteinyl leukotriene type 1 receptor antagonist, attenuates the progression but not the onset of silica-induced pulmonary fibrosis in mice

1 reference

12 December 2020

Oral leukotriene antagonists in thyroid eye disease: myth or reality?

1 reference

12 December 2020

1 reference

12 December 2020

Montelukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patients

1 reference

12 December 2020

The effect of montelukast, budesonide alone, and in combination on exercise-induced bronchoconstriction

1 reference

12 December 2020

Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation

1 reference

12 December 2020

Exercise-induced asthma

1 reference

12 December 2020

A silica-induced pulmonary fibrosis model: are we closer to 'real life'?

1 reference

12 December 2020

Novel therapeutic approach to primary biliary cirrhosis patients: anti-eosinophil strategy

1 reference

12 December 2020

The effect of Zafirlukast on capsule formation in post-radiation silicone implants

1 reference

12 December 2020

Refractory symptoms successfully treated with leukotriene inhibition in a child with systemic mastocytosis

1 reference

12 December 2020

Leukotriene inhibitor may be effective in treatment of psoriasis

1 reference

12 December 2020

Montelukast in childhood asthma: what is the evidence for its use?

1 reference

12 December 2020

A case of diffuse panbronchiolitis effectively treated with low-dose macrolide antibiotics and leukotriene D4/E4 receptor antagonist

1 reference

12 December 2020

Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism

1 reference

12 December 2020

Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis

1 reference

12 December 2020

The evolving role of intravenous leukotriene modifiers in acute asthma

1 reference

12 December 2020

Effect of platelet-activating factor antagonist and leukotriene antagonist on endotoxin shock in the rat: role of the leukocyte

1 reference

12 December 2020

Antileukotrienes and asthma: alternative or adjunct to inhaled steroids?

1 reference

12 December 2020

Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation

1 reference

12 December 2020

Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats

1 reference

12 December 2020

Montelukast therapy and psychological distress in chronic obstructive pulmonary disease (COPD): a preliminary report

1 reference

12 December 2020

Effect of montelukast for treatment of asthma in cigarette smokers

1 reference

12 December 2020

Activation of nitric oxide release and oxidative metabolism by leukotrienes B4, C4, and D4 in human polymorphonuclear leukocytes

1 reference

12 December 2020

Oral montelukast in acute asthma exacerbations: a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Cutting edge: Interleukin 4-dependent mast cell proliferation requires autocrine/intracrine cysteinyl leukotriene-induced signaling

1 reference

12 December 2020

Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria

1 reference

12 December 2020

Montelukast for bronchiolitis obliterans syndrome after lung transplantation

1 reference

12 December 2020

The efficacy and tolerability of intravenous montelukast in acute asthma exacerbations in Japanese patients

1 reference

12 December 2020

Identifiers

DOI

10.1155/2014/608930

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24971371%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24971371%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

24971371

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24971371%20AND%20SRC:MED&resulttype=core&format=json